Outcomes of Using High- or Low-Dose Atorvastatin in Patients 65 Years of Age or Older with Stable Coronary Heart Disease

Figure 3.
Figure 3. Hazard ratios and heterogeneity tests for primary and secondary outcomes among patients 65 years of age or older (solid circles) and those younger than 65 years of age (open circles).

CA = cardiac arrest; CHD = coronary heart disease; CHF = congestive heart failure; CV = cardiovascular; MI = myocardial infarction; PAD = peripheral artery disease; PR = procedure-related. *P value for heterogeneity (patients ≥65 years vs. patients <65 years).

This Article

  1. Ann Intern Med July 3, 2007 vol. 147 no. 1 1-9
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)
  5. Related Information
  6. Audio Summary

Current Issue

  1. December 15, 2009, 151 (12)
  1. Alert me to current issues